sintx.com (SINT): Utang-utang marang kapitalisasi buku

Tandha merek sintx.com (SINT)

This chart of the total debt-to-equity ratio, with a metric value of 0.62, correlates with revenues from the sale of durable silicon nitride antibacterial components. Stable demand for specialized ceramics ensures the business's macro-stability. Sintx Technologies (SINT) is currently reviewing costs, shifting from retail implant sales toward expanding wholesale B2B supplies for medtech.

SINT - Utang-utang marang aset resik Sintx Technologies, Inc. ing rentang 04.07.2022 - 27.10.2026
Produk asli sintx.com

Sintx Technologies (SINT) ceramic production capacities correlate directly with the dynamics of the debt-to-equity ratio. This metric compares total liabilities to shareholders' equity, determining the business's degree of dependence on borrowed funds. This calculation reveals the balance between financial stability and aggressive growth. Moderate leverage is required for diversification into the aviation and medical sectors. Low values confirm high autonomy and asset quality.

Pesaing Sintx Technologies

BSX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku edwards.com EW|RMD: Utang-utang marang kapitalisasi buku|PODD - Utang marang nilai buku|Zimmer Biomet - Utang-utang marang kapitalisasi buku|CooperSurgical (COO) - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku GMED|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku Alphatec Holdings (ATEC)|Utang-utang marang kapitalisasi buku AORT|ENOV - Utang-utang marang aset resik|Utang marang nilai buku Integra LifeSciences|ESTA - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku BBNX|IRADIMED Corp (IRMD) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Embecta Inc. (EMBC)|Rasio utang marang nilai buku Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Utang marang nilai buku|Rasio utang marang aset resik SIBN (si-bone.com)|Orthofix - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Utang-utang marang kapitalisasi buku|TMCI - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Strata Critical Medical Inc|carlsmed.com (CARL) - Rasio utang marang nilai buku|RXST: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik ClearPoint|Utang-utang marang kapitalisasi buku STXS (Stereotaxis Corp)|Utang marang nilai buku Neuronetics, Inc (STIM)|Utang-utang marang kapitalisasi buku SGHT (Sight Sciences, Inc.)|Orchestra BioMed Inc. - Utang-utang marang kapitalisasi buku|ANIK - Rasio utang marang kapitalisasi buku|InspireMD Inc (NSPR) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku zhjmedical.com ZJYL|Vivani Medical (VANI) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku XTNT (Xtant Medical Holdings, Inc.)|Utang-utang marang nilai buku NMTC|MODD: Rasio utang marang kapitalisasi buku|Utang marang aset resik Myomo Inc. MYO|Utang marang nilai buku COCH (Envoy Medical, Inc)|Utang-utang marang kapitalisasi buku Vivos Therapeutics Inc VVOS|Utang-utang marang kapitalisasi buku NVNO (enVVeno Medical)|TNON: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Lifeward (LFWD)|AMIX (Autonomix Medical) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IVF|Utang marang nilai buku Bone Biologics Inc|Axonics, Inc. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku BIOL (biolase.com)|DYNT - Rasio utang marang kapitalisasi buku|FNA - Rasio utang marang nilai buku|Utang marang nilai buku INVO Bio INVO